MARKET

DRIO

DRIO

Dariohealth Corp
NASDAQ

Real-time Quotes | Nasdaq Last Sale

6.37
-0.08
-1.24%
After Hours: 6.37 0 0.00% 16:20 05/19 EDT
OPEN
6.37
PREV CLOSE
6.45
HIGH
6.62
LOW
6.00
VOLUME
314.97K
TURNOVER
0
52 WEEK HIGH
23.80
52 WEEK LOW
4.110
MARKET CAP
140.05M
P/E (TTM)
-1.3752
1D
5D
1M
3M
1Y
5Y
BRIEF-DarioHealth Announces Additional Commercial Contracts for its Digital Therapeutic Solutions
reuters.com · 13h ago
DarioHealth bags two commercial contracts for digital therapeutic solutions
DarioHealth (NASDAQ:DRIO) said on Thursday it had bagged two new contracts to provide digital therapeutics solutions to a national employer and a provider, both of which are expected to begin enrolling members
Seekingalpha · 14h ago
Dariohealth Announces Additional Commercial Contracts For Its Digital Therapeutic Solutions; Terms Not Disclosed
DarioHealth Corp. (NASDAQ:DRIO), a leader in the global digital therapeutics (DTx) market, announced today two new contracts to provide digital therapeutics solutions to a national employer and a provider, both of which
Benzinga · 16h ago
DarioHealth Secures Two Contracts for Digital Therapeutics Services
MT Newswires · 18h ago
Cowen & Co. Maintains Outperform Rating for DarioHealth: Here's What You Need To Know
Cowen & Co. has decided to maintain its Outperform rating of DarioHealth (NASDAQ:DRIO) and raise its price target from $14.00 to $18.00. Shares of DarioHealth are trading up 5.8% over the last 24 hours, at $6.20 per share.
Benzinga · 3d ago
Aegis Capital Adjusts DarioHealth's Price Target to $20 from $23, Keeps Buy Rating
MT Newswires · 3d ago
Cowen Adjusts DarioHealth's Price Target to $18 from $14, Keeps Outperform Rating
MT Newswires · 3d ago
Investors in DarioHealth (NASDAQ:DRIO) from five years ago are still down 89%, even after 32% gain this past week
DarioHealth Corp. ( NASDAQ:DRIO ) has rebounded strongly over the last week, with the share price soaring 32%. But will...
Simply Wall St. · 5d ago
More
No Data
Learn about the latest financial forecast of DRIO. Analyze the recent business situations of Dariohealth Corp through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 7 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

14.29%Strong Buy
85.71%Buy
0.00%Hold
0.00%Under-perform
0.00%Sell
Analyst Price Target
The average DRIO stock price target is 18.34 with a high estimate of 31.00 and a low estimate of 8.75.
High31.00
Average18.34
Low8.75
Current 6.37
EPS
Actual
Estimate
-0.94-0.71-0.47-0.24
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Q2 2022
Institutional Holdings
Institutions: 72
Institutional Holdings: 9.28M
% Owned: 42.53%
Shares Outstanding: 21.99M
TypeInstitutionsShares
Increased
19
937.64K
New
9
69.13K
Decreased
18
269.27K
Sold Out
6
175.31K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
+0.66%
Healthcare Equipment & Supplies
+1.30%
Key Executives
Non-Executive Chairman/Independent Director
Yoav Shaked
President/General Manager
Richard Anderson
Chief Executive Officer/Director
Erez Raphael
Chief Financial Officer/Treasurer/Secretary
Zvi Ben-David
Chief Operating Officer
Dror Bacher
Senior Vice President/Director of Sales
Chris Chan
Senior Vice President
Oded Cohen
Vice President
Claudia Kraut
Other
Jerrod Helms
Director
Adam Stern
Independent Director
Hila Karah
Independent Director
Dennis Matheis
Independent Director
Dennis Mcgrath
Independent Director
Richard Stone
No Data
No Data
About DRIO
DarioHealth Corp. (DarioHealth) is a Digital Therapeutics (DTx) company. DarioHealth operates at the intersection of life sciences, behavioral science, and software technology to deliver integrated and engaging digital therapeutics interventions. The DTx products are centered around its users and include the Dario Blood Glucose Monitoring System and the Dario Smart Diabetes Management Solution, which are provided to its users in the form of a smartphone application that enables the delivery of content and periodical evidence-based reports; the DarioEngage platform, which provides support and two-way real-time connectivity between its users and their caregivers, and Dario Intelligence, which utilizes user data and is an analytics tool that can assist healthcare providers in the treatments and predictability of diseases. The Company’s services are available direct to consumers via online marketplaces including Amazon, Walmart, Best Buy and the Google and Apple app stores.

Webull offers kinds of DarioHealth Corp stock information, including NASDAQ:DRIO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, DRIO stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading DRIO stock methods without spending real money on the virtual paper trading platform.